Arctic Bioscience AS Statistics
Arctic Bioscience AS (9TD) Stock Statistics & Valuation Metrics
Total Valuation
Arctic Bioscience AS has a market cap or net worth of EUR 6.85M. The enterprise value is EUR 167.56M.
- Market Cap
- EUR 6.85M
- Enterprise Value
- EUR 167.56M
Share Statistics
Arctic Bioscience AS has 26,956,257 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 26,956,257
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Arctic Bioscience AS’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -19.62%.
- Return on Equity (ROE)
- -0.23
- Return on Assets (ROA)
- -0.17
- Return on Invested Capital (ROIC)
- -19.62%
- Return on Capital Employed (ROCE)
- -0.23
- Revenue Per Employee
- 2.29M
- Profits Per Employee
- -2.52M
- Employee Count
- 19
- Asset Turnover
- 0.16
- Inventory Turnover
- 1.09
Valuation Ratios
The current PE Ratio of Arctic Bioscience AS is -1.73. Arctic Bioscience AS’s PEG ratio is -3.30.
- PE Ratio
- -1.73
- PS Ratio
- 1.97
- PB Ratio
- 0.39
- Price to FCF
- -0.91
- Price to Operating Cash Flow
- -1.83
- PEG Ratio
- -3.30
Income Statement
In the last 12 months, Arctic Bioscience AS had revenue of 43.48M and earned -47.93M in profits. Earnings per share was -1.88.
- Revenue
- 43.48M
- Gross Profit
- 11.89M
- Operating Income
- -47.79M
- Pretax Income
- -47.93M
- Net Income
- -47.93M
- EBITDA
- -39.63M
- Earnings Per Share (EPS)
- -1.88
Cash Flow
In the last 12 months, operating cash flow was -45.36M and capital expenditures -50.81M, giving a free cash flow of -96.17M billion.
- Operating Cash Flow
- -45.36M
- Free Cash Flow
- -96.17M
- Free Cash Flow per Share
- -3.78
Dividends & Yields
Arctic Bioscience AS pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -109.83%
- Earnings Yield
- -57.80%
Stock Price Statistics
- Beta
- -0.73
- 52-Week Price Change
- -34.67%
- 50-Day Moving Average
- 0.17
- 200-Day Moving Average
- 0.21
- Relative Strength Index (RSI)
- 51.10
- Average Volume (3m)
- ―
Important Dates
Arctic Bioscience AS upcoming earnings date is May 13, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- May 13, 2027
- Ex-Dividend Date
- ―
Financial Position
Arctic Bioscience AS as a current ratio of 0.86, with Debt / Equity ratio of 15.59%
- Current Ratio
- 0.86
- Quick Ratio
- 0.43
- Debt to Market Cap
- 0.67
- Net Debt to EBITDA
- -0.77
- Interest Coverage Ratio
- -15.18
Taxes
In the past 12 months, Arctic Bioscience AS has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Arctic Bioscience AS EV to EBITDA ratio is -2.63, with an EV/FCF ratio of -1.23.
- EV to Sales
- 2.66
- EV to EBITDA
- -2.63
- EV to Free Cash Flow
- -1.23
- EV to Operating Cash Flow
- -2.61
Balance Sheet
Arctic Bioscience AS has EUR 2.16M in cash and marketable securities with EUR 32.86M in debt, giving a net cash position of -EUR 30.70M billion.
- Cash & Marketable Securities
- EUR 2.16M
- Total Debt
- EUR 32.86M
- Net Cash
- -EUR 30.70M
- Net Cash Per Share
- -EUR 1.14
- Tangible Book Value Per Share
- EUR 8.15
Margins
Gross margin is 28.84%, with operating margin of -107.62%, and net profit margin of -107.95%.
- Gross Margin
- 28.84%
- Operating Margin
- -107.62%
- Pretax Margin
- -107.95%
- Net Profit Margin
- -107.95%
- EBITDA Margin
- -101.12%
- EBIT Margin
- -107.62%
Analyst Forecast
The average price target for Arctic Bioscience AS is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 7.41%
- EPS Growth Forecast
- 9.32%

